¼¿ï´ëÇб³º´¿ø SNUH Update symposium : 2021-12-11±³À°ÀÏÀÚ : 2021-12-11
±³À°Àå¼Ò : ¿Â-¿ÀÇÁ¶óÀÎ ±³À° (¸óµå¸®¾È ¼¿ï ÀÌÅ¿ø ±×·£µåº¼·ë1)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ,¿ÀÇÁ¶óÀÎ º´Çà) SNUH Update symposiumÁÖÃÖ±â°ü : ¼¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÈäºÎ¿Ü°ú
´ã´çÀÚ : ¼Ò¶ó
¿¬¶ôó : 02-2072-2347
À̸ÞÀÏ :
srsr@snuh.org ±³À°Á¾·ù : ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 21ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í Àü¹®ÀÇ 2¸¸¿ø / Àü°øÀÇ,°£È£»ç, ±âŸ 1¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 08:30~08:45 The importance of cardiac rehabilitation and fitness in patients with congenital heart disease Naomi Gauthier(Harvard medical school Boston Children)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 08:45~09:00 Methods to evaluate, collect and measure results of our efforts to patients Naomi Gauthier(Harvard medical school Boston Children)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:00~09:12 Our practice (Boston Children¡¯s Hospital) and program in detail Tracy Curran(Boston Children)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:12~09:24 Unexpected events during cardiac fitness program: How to deal with these situations? Tracy Curran(Boston Children)
Åä·Ð 12-11 ±×·£µåº¼·ë1 09:24~09:39 discussion 1.¹Úõ¼ö 2.¼Û¹Ì°æ(1.¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú 2.¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú)
ÈÞ½Ä 12-11 ±×·£µåº¼·ë1 09:39~09:44 ÈÞ½Ä ()
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:44~09:56 Interpretation of CPET and application in real world ÀÌ»óÀ±(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:56~10:08 Exercercise recommendation for congenital heart diseases ÀÌÀ¯Çü(¼¿ïÀÇ´ë ¼¿ï´ë¾î¸°À̺´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 10:08~10:20 Practices in Seoul ±èÇöÁ¤(¼¿ï½Ã¸³´ë ½ºÆ÷Ã÷°úÇаú)
Åä·Ð 12-11 ±×·£µåº¼·ë1 10:20~10:35 Discussion 1.±è¼öÁø 2.¹ÚÇѱâ(1.ºÎõ¼¼Á¾º´¿ø ¼Ò¾Æû¼Ò³â°ú 2.¿¬¼¼ÀÇ´ë ½ÅÃ̼¼ºê¶õ½ºº´¿ø ÈäºÎ¿Ü°ú)
ÈÞ½Ä 12-11 ±×·£µåº¼·ë1 10:35~10:40 ÈÞ½Ä ()
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 10:40~10:52 Nutritional recommendation in single ventricle patients ±èÁö¿µ(¼¿ï´ëº´¿ø ¾î¸°À̺´¿ø ¿µ¾ç°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 10:52~11:04 Psychological management and support for congenital caridac diseases in postoperative period ÀÌÁ¤(¼¿ïÀÇ´ë ¼¿ï´ë¾î¸°À̺´¿ø Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 11:04~11:16 Quality of life after congenital caridac surgery ÇãÁ¾È£(¼¿ïÀÇ´ë ÀÌÁ¾¿í ±Û·Î¹ú ¼¾ÅÍ º¸°ÇÇÐ ÀÚ¹®À§¿ø ±¹È¸ ¹Ì·¡ ¿¬±¸¿ø)
Åä·Ð 12-11 ±×·£µåº¼·ë1 11:16~11:31 Discussion 1.¼ÛÁø¿µ 2.±èÇüÅÂ(1.¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø ¼Ò¾Æû¼Ò³â°ú 2.ºÎ»êÀÇ´ë ¾ç»êºÎ»ê´ëº´¿ø ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 12:00~12:30 Special lecture: Lung transplant for severe COVID-19 TBA(Toronto General Hospital)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 12:30~12:50 Lung transplant for severe COVID-19 in Korea Àü°æ¸¸(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø È£Èí±â³»°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 12:50~13:10 Extracorporeal Membrane Oxygenation for COVID-19: Technical aspects and outcomes Á¤Àμ®(Àü³²ÀÇ´ë Àü³²´ëº´¿ø ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 13:10~13:30 Extracorporeal membrane oxygenation support in COVID-19: Current status of national cohort studies ¼Õ±¹Èñ(°¡ÃµÀÇ´ë ±æº´¿ø ÈäºÎ¿Ü°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 13:30~13:50 Extracorporeal membrane oxygenation support in COVID-19: SNUH experience ¹Ú»ùÀ̳ª(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø ÈäºÎ¿Ü°ú)
Åä·Ð 12-11 ±×·£µåº¼·ë1 13:50~14:00 Discussion chair 1.¹éȿä 2.ÃÖ¿ë¼ö(1.¿¬¼¼ÀÇ´ë ½ÅÃ̼¼ºê¶õ½ºº´¿ø ÈäºÎ¿Ü°ú 2.¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø ÈäºÎ¿Ü°ú)
ÈÞ½Ä 12-11 ±×·£µåº¼·ë1 14:00~14:10 ÈÞ½Ä ()
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 14:10~14:30 Genetic susceptibility to severe COVID-19 ¹ÚÁö¸í(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø È£Èí±â³»°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 14:30~14:50 Studying COVID-19 with lung organoids ÁÖ¿µ¼®(Ä«À̽ºÆ®)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 14:50~15:10 Vaccination for COVID-19 °Ã¢°æ(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø °¨¿°³»°ú)
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 15:10~15:30 Thoracic surgery after the COVID-19 pandemic ³ª±ÇÁß(¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø ÈäºÎ¿Ü°ú)
Åä·Ð 12-11 ±×·£µåº¼·ë1 15:30~15:40 Discussion chair 1.±èµ¿°ü 2.ÀÌÈ£¼®(1.¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú 2.ºÎ»êÀÇ´ë ºÎ»ê´ëº´¿ø ÈäºÎ¿Ü°ú)